Agency president Donna Pepe said: ‘[Seasonale] takes things beyond birth control, and puts women in charge of their menstrual cycles.’
Pepe added that CSI would attempt to increase awareness surrounding ‘the whole concept of fewer periods’, something she described as ‘very empowering’.
To combat concern about the health risks associated with reducing the frequency of periods, most of CSI’s efforts, according to Pepe, will focus on education.
She said that Barr is anticipating a ‘late-summer approval’ for Seasonale, which
is currently being reviewed
by the US Food and Drug Administration.